Overall HLVX gets a fundamental rating of 3 out of 10. We evaluated HLVX against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for HLVX as it has an excellent financial health rating, but there are worries on the profitability. HLVX has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year HLVX has reported negative net income.
In the past year HLVX has reported a negative cash flow from operations.
HLVX had negative earnings in each of the past 5 years.
In the past 5 years HLVX always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -40.65%, HLVX perfoms like the industry average, outperforming 58.70% of the companies in the same industry.
HLVX has a better Return On Equity (-48.10%) than 66.48% of its industry peers.

		Industry Rank	Sector Rank
ROA	-40.65%
ROE	-48.1%
ROIC	N/A

ROA(3y)-54.23%

ROA(5y)-132.64%

ROE(3y)-67.22%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HLVX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HLVX has more shares outstanding than it did 1 year ago.
HLVX has more shares outstanding than it did 5 years ago.
HLVX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -1.98, we must say that HLVX is in the distress zone and has some risk of bankruptcy.
HLVX has a Altman-Z score of -1.98. This is comparable to the rest of the industry: HLVX outperforms 52.22% of its industry peers.
HLVX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-1.98

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

HLVX has a Current Ratio of 26.39. This indicates that HLVX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 26.39, HLVX belongs to the top of the industry, outperforming 97.41% of the companies in the same industry.
A Quick Ratio of 26.39 indicates that HLVX has no problem at all paying its short term obligations.
The Quick ratio of HLVX (26.39) is better than 97.41% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	26.39
Quick Ratio	26.39

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.82% over the past year.

EPS 1Y (TTM)57.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.75%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, HLVX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.16% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y83.34%

EPS Next 2Y35.78%

EPS Next 3Y22.84%

EPS Next 5Y10.16%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HLVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HLVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.